0001810705-24-000001.txt : 20240715
0001810705-24-000001.hdr.sgml : 20240715
20240715162757
ACCESSION NUMBER: 0001810705-24-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20240715
DATE AS OF CHANGE: 20240715
EFFECTIVENESS DATE: 20240715
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Transposon Therapeutics, Inc.
CENTRAL INDEX KEY: 0001810705
ORGANIZATION NAME:
IRS NUMBER: 843996895
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-518803
FILM NUMBER: 241117568
BUSINESS ADDRESS:
STREET 1: 2765 SAND HILL ROAD
STREET 2: C/O CANAAN PARTNERS
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: (949) 422-9676
MAIL ADDRESS:
STREET 1: 2765 SAND HILL ROAD
STREET 2: C/O CANAAN PARTNERS
CITY: MENLO PARK
STATE: CA
ZIP: 94025
D
1
primary_doc.xml
X0708
D
LIVE
0001810705
Transposon Therapeutics, Inc.
4660 La Jolla Village Drive
Suites 100 & 200
San Diego
CA
CALIFORNIA
92112
(949) 422-9676
DELAWARE
None
None
Corporation
true
2019
Lynne
R.
Rollins
4660 La Jolla Village Drive
Suites 100 & 200
San Diego
CA
CALIFORNIA
92122
Executive Officer
Eckard
Weber, MD
4660 La Jolla Village Drive
Suites 100 & 200
San Diego
CA
CALIFORNIA
92122
Executive Officer
Director
Brent
Ahrens
4660 La Jolla Village Drive
Suites 100 & 200
San Diego
CA
CALIFORNIA
92122
Director
John
Pacifico
4660 La Jolla Village Drive
Suites 100 & 200
San Diego
CA
CALIFORNIA
92122
Director
William
Harrington, MD, MBA
4660 La Jolla Village Drive
Suites 100 & 200
San Diego
CA
CALIFORNIA
92122
Director
Daniel
Hetu, MD, MBA
4660 La Jolla Village Drive
Suites 100 & 200
San Diego
CA
CALIFORNIA
92122
Director
Keith
A.
Katkin
4660 La Jolla Village Drive
Suites 100 & 200
San Diego
CA
CALIFORNIA
92122
Director
Brian
Taylor
Slingsby, MD, PHD, MPH
4660 La Jolla Village Drive
Suites 100 & 200
San Diego
CA
CALIFORNIA
92122
Director
Dennis
Podlesak
4660 La Jolla Village Drive
Suites 100 & 200
San Diego
CA
CALIFORNIA
92122
Executive Officer
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2024-07-10
false
true
true
true
false
0
20000000
4679395
15320605
false
8
0
0
0
false
Transposon Therapeutics, Inc.
Dennis G. Podlesak
Dennis G. Podlesak
Chief Executive Officer
2024-07-15